UofT Libraries is getting a new library services platform in January 2021.
Learn more about the change.
Search Articles
The lancet oncology, ISSN 1470-2045, 2012, Volume 13, Issue 10, pp. 1011 - 1019
Hematology, Oncology and Palliative Medicine | Life Sciences & Biomedicine | Oncology | Science & Technology | Lung Neoplasms - drug therapy | Pyrazoles - therapeutic use | Lung Neoplasms - enzymology | Lung Neoplasms - mortality | Humans | Middle Aged | Male | Protein Kinase Inhibitors - adverse effects | Carcinoma, Non-Small-Cell Lung - mortality | Pyridines - adverse effects | Protein Kinase Inhibitors - therapeutic use | Aged, 80 and over | Receptor Protein-Tyrosine Kinases - antagonists & inhibitors | Adult | Female | Receptor Protein-Tyrosine Kinases - analysis | Aged | Carcinoma, Non-Small-Cell Lung - drug therapy | Carcinoma, Non-Small-Cell Lung - enzymology | Pyrazoles - adverse effects | Pyridines - therapeutic use | Care and treatment | Safety and security measures | Genes | Oncology, Experimental | Research | Lung cancer, Non-small cell | Cancer | Index Medicus
Journal Article
The lancet oncology, ISSN 1470-2045, 2011, Volume 12, Issue 11, pp. 1004 - 1012
Hematology, Oncology and Palliative Medicine | Life Sciences & Biomedicine | Oncology | Science & Technology | Lung Neoplasms - drug therapy | Pyrazoles - therapeutic use | Lung Neoplasms - mortality | United States | Humans | Middle Aged | Lung Neoplasms - pathology | Male | Antineoplastic Agents - therapeutic use | Patient Selection | Multicenter Studies as Topic | Time Factors | Receptor Protein-Tyrosine Kinases - antagonists & inhibitors | Adult | Female | Retrospective Studies | Pyridines - therapeutic use | Carcinoma, Non-Small-Cell Lung - pathology | Lung Neoplasms - genetics | Lung Neoplasms - enzymology | Risk Assessment | Carcinoma, Non-Small-Cell Lung - genetics | Risk Factors | Kaplan-Meier Estimate | Proportional Hazards Models | Survival Rate | Treatment Outcome | Carcinoma, Non-Small-Cell Lung - mortality | Receptor Protein-Tyrosine Kinases - genetics | Protein Kinase Inhibitors - therapeutic use | Gene Rearrangement | Aged | Carcinoma, Non-Small-Cell Lung - drug therapy | Carcinoma, Non-Small-Cell Lung - enzymology | Australia | Clinical Trials, Phase I as Topic | Care and treatment | Analysis | Patient outcomes | Genetic research | Genetic aspects | Lung cancer, Non-small cell | Cancer | Index Medicus
Journal Article
The New England journal of medicine, ISSN 0028-4793, 07/2015, Volume 373, Issue 5, pp. 428 - 437
Medicine, General & Internal | Life Sciences & Biomedicine | General & Internal Medicine | Science & Technology | Aminopyridines - administration & dosage | Receptor, Macrophage Colony-Stimulating Factor - antagonists & inhibitors | Pyrroles - pharmacokinetics | Humans | Middle Aged | Aminopyridines - pharmacokinetics | Aminopyridines - adverse effects | Giant Cell Tumors - pathology | Soft Tissue Neoplasms - drug therapy | Crystallography, X-Ray | Male | Tumor Burden | Drug Discovery | Receptor, Macrophage Colony-Stimulating Factor - metabolism | Dose-Response Relationship, Drug | Giant Cell Tumors - drug therapy | Pyrroles - administration & dosage | Tendons - pathology | Soft Tissue Neoplasms - pathology | Pyrroles - adverse effects | Adult | Female | Aged | Treatment outcome | Colony-stimulating factors (Physiology) | Care and treatment | Dosage and administration | Giant cell tumors | Analysis | Edema | Genes | Macrophage colony-stimulating factor | Fatigue | Nausea | Kinases | Crystallography | Patients | Colony-stimulating factor | Drug discovery | Solid tumors | Drug therapy | Conformation | Tumors | Index Medicus | Abridged Index Medicus
Journal Article
The New England journal of medicine, ISSN 0028-4793, 02/2011, Volume 364, Issue 6, pp. 588 - 588
Journal Article
EMBO molecular medicine, ISSN 1757-4676, 05/2010, Volume 2, Issue 5, pp. 146 - 158
cancer | profiling | targeted therapies | genotyping | Targeted therapies | Profiling | Genotyping | Cancer | Life Sciences & Biomedicine | Medicine, Research & Experimental | Science & Technology | Research & Experimental Medicine | Clinical Laboratory Techniques - methods | Neoplasms - therapy | Neoplasms - genetics | Humans | Genotype | Mutation | DNA Mutational Analysis - methods | Precision Medicine - methods | Polymerase Chain Reaction - methods | Medical research | Laboratories | Genes | Embedding | Histology | Genomes | Phosphatase | Paraffin | Kinases | Patients | Cancer therapies | Deoxyribonucleic acid--DNA | Tumors | Index Medicus | Reports
Journal Article
Nature (London), ISSN 0028-0836, 12/2007, Volume 450, Issue 7173, pp. 1235 - 1239
Science & Technology - Other Topics | Multidisciplinary Sciences | Science & Technology | Biological and medical sciences | Multiple tumors. Solid tumors. Tumors in childhood (general aspects) | Medical sciences | Tumors | Microarray Analysis - methods | Neoplastic Cells, Circulating - pathology | Microarray Analysis - instrumentation | Humans | Male | Neoplasms - diagnosis | Cell Separation - methods | Neoplasms - drug therapy | Microfluidics - instrumentation | Neoplasm Metastasis | Neoplasms - blood | Sensitivity and Specificity | Female | Neoplasms - pathology | Microfluidics - methods | Medical research | Semiconductors | Oncology | Medical diagnosis | Cells | Blood | Cancer | Index Medicus
Journal Article
Journal of clinical oncology, ISSN 0732-183X, 03/2012, Volume 30, Issue 8, pp. 863 - 870
Life Sciences & Biomedicine | Oncology | Science & Technology | Tumors of the respiratory system and mediastinum | Biological and medical sciences | Medical sciences | Tumors | Pneumology | Lung Neoplasms - drug therapy | Pyrazoles - therapeutic use | Lung Neoplasms - mortality | Humans | Middle Aged | Male | Protein-Tyrosine Kinases - genetics | Aged, 80 and over | Adult | Female | Adenocarcinoma - genetics | Retrospective Studies | Pyrazoles - pharmacology | Pyridines - therapeutic use | Lung Neoplasms - genetics | Carcinoma, Non-Small-Cell Lung - genetics | In Situ Hybridization, Fluorescence | Proto-Oncogene Proteins - genetics | Treatment Outcome | Carcinoma, Non-Small-Cell Lung - mortality | Receptor Protein-Tyrosine Kinases - genetics | Protein Kinase Inhibitors - therapeutic use | Gene Rearrangement | Aged | Protein Kinase Inhibitors - pharmacology | Pyridines - pharmacology | Carcinoma, Non-Small-Cell Lung - drug therapy | Drug Screening Assays, Antitumor | Index Medicus | Original Reports | Thor9 | Thor2 | Thor12
Journal Article
Journal of clinical oncology, ISSN 0732-183X, 09/2009, Volume 27, Issue 26, pp. 4247 - 4253
Tumors of the respiratory system and mediastinum | Biological and medical sciences | Medical sciences | Tumors | Pneumology | Erlotinib Hydrochloride | Immunohistochemistry | Lung Neoplasms - drug therapy | Receptor, Epidermal Growth Factor - genetics | Oncogene Proteins, Fusion - metabolism | Age Factors | Protein-Tyrosine Kinases - metabolism | Humans | Middle Aged | Lung Neoplasms - pathology | Male | Protein-Tyrosine Kinases - genetics | Aged, 80 and over | Adult | Female | Quinazolines - administration & dosage | Genes, ras - genetics | Carcinoma, Non-Small-Cell Lung - pathology | Lung Neoplasms - genetics | Carcinoma, Non-Small-Cell Lung - genetics | Kaplan-Meier Estimate | Genotype | In Situ Hybridization, Fluorescence | Treatment Outcome | Receptor Protein-Tyrosine Kinases | Protein Kinase Inhibitors - administration & dosage | Antineoplastic Combined Chemotherapy Protocols - therapeutic use | Oncogene Proteins, Fusion - genetics | Sex Factors | Aged | Carcinoma, Non-Small-Cell Lung - drug therapy | Mutation | Index Medicus | Original Reports | Thoracic Oncology | Thor12 | To8 | To20
Journal Article
The lancet oncology, ISSN 1470-2045, 2010, Volume 11, Issue 1, pp. 48 - 54
Hematology, Oncology and Palliative Medicine | Life Sciences & Biomedicine | Oncology | Science & Technology | Humans | Middle Aged | Antibodies, Monoclonal - adverse effects | Antineoplastic Combined Chemotherapy Protocols - adverse effects | Antibodies, Monoclonal - therapeutic use | Male | Positron-Emission Tomography | Biliary Tract Neoplasms - mortality | Bevacizumab | Antibodies, Monoclonal, Humanized | Deoxycytidine - therapeutic use | Time Factors | Aged, 80 and over | Angiogenesis Inhibitors - therapeutic use | Biliary Tract Neoplasms - diagnostic imaging | Adult | Deoxycytidine - adverse effects | Female | Biliary Tract Neoplasms - drug therapy | Radiopharmaceuticals | Angiogenesis Inhibitors - adverse effects | Risk Assessment | Kaplan-Meier Estimate | Proportional Hazards Models | Treatment Outcome | Disease-Free Survival | Antineoplastic Combined Chemotherapy Protocols - therapeutic use | Fluorodeoxyglucose F18 | Aged | Organoplatinum Compounds - therapeutic use | Deoxycytidine - analogs & derivatives | Organoplatinum Compounds - adverse effects | Index Medicus
Journal Article
Journal of clinical oncology, ISSN 0732-183X, 12/2011, Volume 29, Issue 36, pp. 4803 - 4810
Life Sciences & Biomedicine | Oncology | Science & Technology | Biological and medical sciences | Medical sciences | Tumors | Receptor, Epidermal Growth Factor - genetics | Pyrazoles - therapeutic use | Adenocarcinoma - pathology | Humans | Middle Aged | Male | Stomach Neoplasms - pathology | Esophageal Neoplasms - pathology | Aged, 80 and over | Adult | Female | Adenocarcinoma - genetics | Pyridines - therapeutic use | Stomach Neoplasms - genetics | Proto-Oncogene Proteins c-met - antagonists & inhibitors | Stomach Neoplasms - drug therapy | Adenocarcinoma - drug therapy | Proto-Oncogene Proteins c-met - genetics | Gene Amplification | Esophageal Neoplasms - genetics | Genes, erbB-2 | Protein Kinase Inhibitors - therapeutic use | Aged | Esophageal Neoplasms - drug therapy | Cohort Studies | Index Medicus | Original Reports | Gic9 | Gic37 | Gic14 | Gic42
Journal Article